Progesterone in the Treatment of Acute Hemorrhagic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 184 participants.
Also called NCT04143880
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 184 participants
- Sponsor
- Registry
-
NCT04143880
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04143880. Randomized; double masking; primary purpose treatment. Start 2020-02-01 (anticipated); primary completion 2020-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Progesterone in the Treatment of Acute Hemorrhagic Stroke
- Condition
- Stroke
- Intervention (Drug)
- Progesterone
- Intervention (Other)
- saline
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator
- Korea University Anam Hospital
- Collaborator
- Seoul National University Hospital
- Collaborator
- Lishui Country People's Hospital
- Collaborator
- Jinhua Central Hospital
- Collaborator
- Huzhou Central Hospital
- Collaborator
- The Affiliated Hospital of Hangzhou Normal University
Record details
- Record id
cardio:ct-nct04143880- Content hash
e6ebcd5f8c4a7519918e3cecb933430bd4e6131e27d5643b766117a5b3aaeba8